Reuters: Merck says FDA rejects its new cholesterol drug

[NaDiNe]

Merck says FDA rejects its new cholesterol drug
      

NEW YORK (Reuters) - U.S. health regulators have rejected Merck & Co Inc's new drug designed to raise the level of HDL, or "good" cholesterol, the company said on Monday, sending its shares down 5 percent.
<p>You are not allowed to view links. Register or Login</p><div class="feedflare">
You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login
</div><img src="You are not allowed to view links. Register or Login" height="1" width="1"/>
      

You are not allowed to view links. Register or Login